CDI Laboratory Develops Promising New Antibiotic for Resistant Gonorrhea
8/23/2022 12:00 AM
Compound could be a game-changer for dangerous pathogen
A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI) shows great promise in eradicating the bacteria causing gonorrhea, according to a new publication.